Accentrate Pnv Kit
NDC Package 70868-510-30
Package Information
Accentrate Pnv (prenatal multivitamin tablet and combination omega-3 softgel/mineral capsule) kits is accentrate® PNV (Folate/Omega-3/Iron) (6 mg-210 mg-10 mg) is a Prescription Prenatal Multivitamin Tablet and combination Omega-3 Softgel/Mineral Capsule indicated for preventing neural tube defects and use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. This formulation utilizes a kit delivery system. Marketed by Key Therapeutics, this product is identified by NDC 70868-510.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70868 - Key Therapeutics
- 70868-510 - Accentrate Pnv
- 70868-510-30 - 1 KIT in 1 CARTON * 60 CAPSULE in 1 BOTTLE (70868-512-30) * 90 CAPSULE in 1 BOTTLE (70868-513-30) * 30 TABLET in 1 BOTTLE (70868-511-30)
- 70868-510 - Accentrate Pnv
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70868-510-30 identifies a specific commercial package of 1 kit in 1 carton * 60 capsule in 1 bottle (70868-512-30) * 90 capsule in 1 bottle (70868-513-30) * 30 tablet in 1 bottle (70868-511-30) of Accentrate Pnv, a human prescription drug labeled by Key Therapeutics. This kit is formulated for oral use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Key Therapeutics on February 17, 2025. The current certification is valid through December 31, 2026.
How is this Key Therapeutics product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70868051030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.